Actively Recruiting
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Led by Pamukkale University · Updated on 2024-12-27
10
Participants Needed
1
Research Sites
202 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
CONDITIONS
Official Title
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with sensorineural hearing loss
- Patients who will have cochlear implant surgery with CI422 electrode
You will not qualify if you...
- Patients with cochlear abnormality
- Patients with auditory neuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pamukkale University
Denizli, Turkey (Türkiye), 20070
Actively Recruiting
Research Team
F
Fazil N Ardic, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here